Daniel, Rachel A <br/><br/>
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2009 
 - 1241-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-08-1095  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dacarbazine--analogs & derivatives<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Indoles--pharmacology<br/>Mice<br/>Neuroblastoma--drug therapy<br/>Poly (ADP-Ribose) Polymerase-1<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Temozolomide<br/>Topotecan--pharmacology<br/>Xenograft Model Antitumor Assays